We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$36M
(-19%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-30.71%
Top 10 Holdings %
Top 10 Hldgs %
41.15%
Holding
341
New
79
Increased
30
Reduced
42
Closed
62
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.8
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
2.9
quarters
Top 20 Avg Time Held Equity only
3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.19M |
| 2 |
LL Flooring Holdings, Inc.
LL
|
+$1.02M |
| 3 |
McDonald's
MCD
|
+$949K |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$869K |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.08M |
| 2 |
Esperion Therapeutics
ESPR
|
+$1.61M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$1.07M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.06M |
| 5 |
Loews
L
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.42% |
| 2 | Miscellaneous | 30.29% |
| 3 | Healthcare | 15.66% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Technology | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ENT
101
DELISTED
Global Eagle Entertainment Inc.
ENT
| $333K | 0.22% |
1,000
+600
| +150% | +$211K |
2014 Q3
2 quarters
|
|
102
DELISTED
Kellanova
K
| $330K | 0.22% |
5,325
| – | – |
2014 Q4
1 quarter
|
|
103
Caleres
CAL
$421M
| $328K | 0.22% |
+10,000
| New | +$305K |
2015 Q1
0 quarters
|
|
|
104
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
| $308K | 0.21% |
+10,000
| New | +$511K |
2015 Q1
0 quarters
|
|
|
ADEP
105
CALL
DELISTED
Adept Technology Inc
ADEP
| $308K | 0.21% |
+50,000
| New | +$368K |
2015 Q1
0 quarters
|
|
|
JUNO
106
DELISTED
Juno Therapeutics, Inc.
JUNO
| $303K | 0.2% |
+5,000
| New | +$243K |
2015 Q1
0 quarters
|
|
107
Novavax
NVAX
$2.09B
| $295K | 0.2% |
1,786
-724
| -29% | -$118K |
2013 Q4
5 quarters
|
|
|
JMBA
108
DELISTED
Jamba, Inc.
JMBA
| $294K | 0.2% |
20,000
-10,000
| -33% | -$153K |
2014 Q4
1 quarter
|
|
|
FRE.PRZ
109
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
| $291K | 0.19% |
70,000
| – | – |
2013 Q2
7 quarters
|
|
|
KITE
110
DELISTED
Kite Pharma, Inc.
KITE
| $288K | 0.19% |
5,000
-10,000
| -67% | -$670K |
2014 Q4
1 quarter
|
|
|
LUB
111
DELISTED
Luby's Inc.
LUB
| $285K | 0.19% |
55,000
+35,000
| +175% | +$178K |
2013 Q2
7 quarters
|
|
112
RAVE Restaurant Group
RAVE
$32M
| $279K | 0.19% |
20,000
+5,000
| +33% | +$60.6K |
2014 Q4
1 quarter
|
|
113
Beacon Financial Corp
BBT
$2.29B
| $277K | 0.18% |
10,000
| – | – |
2013 Q2
7 quarters
|
|
114
Ethan Allen Interiors
ETD
$512M
| $276K | 0.18% |
+10,000
| New | +$285K |
2015 Q1
0 quarters
|
|
115
Las Vegas Sands
LVS
$23.4B
| $275K | 0.18% |
5,000
| – | – |
2014 Q3
2 quarters
|
|
116
Tejon Ranch
TRC
$442M
| $265K | 0.18% |
10,300
| – | – |
2013 Q3
6 quarters
|
|
117
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $262K | 0.17% |
+32,500
| New | +$245K |
2015 Q1
0 quarters
|
|
118
Incyte
INCY
$22.6B
| $257K | 0.17% |
+2,800
| New | +$231K |
2015 Q1
0 quarters
|
|
119
Investar Holding Corp
ISTR
$400M
| $257K | 0.17% |
15,000
| – | – |
2014 Q3
2 quarters
|
|
|
KYTH
120
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $251K | 0.17% |
+5,000
| New | +$210K |
2015 Q1
0 quarters
|
|
121
First Northwest Bancorp
FNWB
$93.7M
| $250K | 0.17% |
+20,000
| New | +$249K |
2015 Q1
0 quarters
|
|
|
XLRN
122
DELISTED
Acceleron Pharma
XLRN
| $247K | 0.16% |
6,500
| – | – |
2014 Q4
1 quarter
|
|
123
Iridium Communications
IRDM
$4.99B
| $243K | 0.16% |
+25,000
| New | +$233K |
2015 Q1
0 quarters
|
|
|
MYCC
124
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $242K | 0.16% |
+12,500
| New | +$225K |
2015 Q1
0 quarters
|
|
125
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $240K | 0.16% |
+10,030
| New | +$225K |
2015 Q1
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2015 Portfolio in Review
As of Q1 2015, E.E. Geduld held 341 positions worth $150M, down 19% from $186M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
E.E. Geduld withdrew a net $46M in Q1 2015, closing 62 positions and reducing 42 holdings. Its most notable exit was Alibaba, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Celgene Corp worth $1.15M.
- E.E. Geduld's largest Q1 2015 buy was Celgene Corp: 10,000 shares worth $1.15M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q1 2015, an estimated $869K increase.
- E.E. Geduld's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $1.61M.
- E.E. Geduld fully exited Alibaba in Q1 2015, selling an estimated $2.08M.
- E.E. Geduld's ten largest holdings make up 41% of its $150M portfolio in Q1 2015.
- E.E. Geduld opened 79 new positions and closed 62 in Q1 2015.
- E.E. Geduld's portfolio value fell 19% quarter-over-quarter to $150M.
Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.